Program in Chemical Biology, University of Michigan, Ann Arbor, MI, USA.
Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
FEBS Lett. 2020 Apr;594(8):1307-1318. doi: 10.1002/1873-3468.13721. Epub 2019 Dec 31.
Phosphorylation of translational repressor eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) controls the initiation of cap-dependent translation, a type of protein synthesis that is frequently upregulated in human diseases such as cancer. Because of its critical cellular function, it is not surprising that multiple kinases can post-translationally modify 4E-BP1 to drive aberrant cap-dependent translation. We recently reported a site-selective chemoproteomic method for uncovering kinase-substrate interactions, and using this approach, we discovered the cyclin-dependent kinase (CDK)4 as a new 4E-BP1 kinase. Herein, we describe our extension of this work and reveal the role of CDK4 in modulating 4E-BP1 activity in the transition from mitosis to G1, thereby demonstrating a novel role for this kinase in cell cycle regulation.
磷酸化翻译抑制剂真核翻译起始因子 4E(eIF4E)结合蛋白 1(4E-BP1)控制着帽依赖型翻译的起始,这种蛋白合成类型在人类疾病(如癌症)中经常被上调。由于其关键的细胞功能,多种激酶可以对 4E-BP1 进行翻译后修饰,以驱动异常的帽依赖型翻译,这并不奇怪。我们最近报道了一种用于揭示激酶-底物相互作用的位点选择性化学蛋白质组学方法,并且使用这种方法,我们发现周期蛋白依赖性激酶(CDK)4 是 4E-BP1 的一种新激酶。在此,我们描述了这项工作的扩展,并揭示了 CDK4 在有丝分裂到 G1 过渡过程中调节 4E-BP1 活性的作用,从而证明了该激酶在细胞周期调控中的新作用。